Search

everythinglearnresearchcommunity

for

Search:↓

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Certain hairstyles can cause scalp diseases, smoking is linked to hair loss, 5% minoxidil foam is effective for hair loss treatment, and various factors influence wound healing and hair growth.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Use minoxidil for hair loss; finasteride and dutasteride for men, dutasteride for women.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that surgery is a preferred treatment for cicatricial alopecia, with the method chosen based on individual factors and may require multiple sessions and careful postoperative care.

Microsurgical reconstruction effectively covers complex scalp defects but doesn't improve survival for cancer-related cases.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The normal range for the hair pull test is 2 hairs or fewer, and washing or brushing hair before the test does not affect the results.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

The document explains how to identify different hair problems using a microscope.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

PRP injections help regrow hair, reduce hair loss, and increase hair thickness, but effects decrease without ongoing treatment.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

Captopril may cause hair loss, as shown by a woman's hair regrowing after stopping the medication.